Steven Boranian, Reed SmithJanuary 3, 2017, 4:56 PM EST
Law360, New York (January 3, 2017, 4:56 PM EST) -- It took us a long time to understand how off-label promotion of prescription drugs had anything to do with the False Claims Act, and we’re still not so sure that the two are a fit. The FCA penalizes anyone who presents, or causes to be presented, to the federal government “a false or fraudulent claim for payment or approval.” 31 U.S.C. § 3729(a)(1).
Easy, right? Congress enacted the FCA after the Civil War to curb abuses in government procurement. That part we get. If you sell...
Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.